Acta Vet. Brno 2013, 82: 289-296
https://doi.org/10.2754/avb201382030289
Effect of diets with different fat contents on the development of diabetes in female Zucker diabetic fatty rat with leptin mutation
References
1. 2003: Monitoring of antioxidative effect of morine in alloxan-induced diabetes mellitus in the laboratory rat. Acta Vet Brno 72: 191-200
< L, Necas J, Suchy V, Kubinova R, Vesela D, Benes L, Bartosik T, Illek J, Salplachta J, Klusakova J, Bartosova L, Strnadova V, Frana P, Franova J https://doi.org/10.2754/avb200372020191>
2. 1999: Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J Surg Res 84: 31-34
< KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ https://doi.org/10.1006/jsre.1999.5599>
3. 2007: Nitric oxide donors selectively reduce the expression of matrix metalloproteinases- 8 and -9 by human diabetic skin fibroblasts. J Surg Res 140: 90-98
< JW, Koch JA, Chuang HH, Zhong W, Dean DD, Sylvia VL https://doi.org/10.1016/j.jss.2006.11.010>
4. 2000: Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 148: 231-241
< JP, Sparks JD, Peterson RG. Smith RL, Sparks CE https://doi.org/10.1016/S0021-9150(99)00265-8>
5. 2001: Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50: 1021-1029
< DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE https://doi.org/10.2337/diabetes.50.5.1021>
6. 2010: Factors affecting wound healing. J Dent Res 89: 219-229
< S, DiPietro LA https://doi.org/10.1177/0022034509359125>
7. 2006: Composition of wound fluid from pressure ulcers treated with negative pressure wound therapy using V.A.C. therapy in home health or extended care patients: A pilot study. Wounds 18: 119-126
DV, Stechmiller JK, Cowan L, Kieswetter K, Schultz G, Bellis SL
8. 2005: Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 42: 162-170
< BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ https://doi.org/10.1007/s00592-005-0197-8>
9. 2002: Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45: 1011-1016
< R, Ambrosch A, Schultz G, Waldman K, Schiweck S, Lehnert H https://doi.org/10.1007/s00125-002-0868-8>
10. 2008: Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats. Acta Vet Brno 77: 175-182
< A, Mojzis J, Benacka R, Keller J, Maguth T, Kurila P, Vaško L, Rácz O, Ništiar F https://doi.org/10.2754/avb200877020175>
11. 2011: Tight glycaemic control is a key factor in wound healing enhancement strategies in an experimental diabetes mellitus model. Ir J Med Sci 180: 229-236
< JB, Hanson R, Chan F, Bouchier-Hayes DJ https://doi.org/10.1007/s11845-010-0630-z>
12. 2005: Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models. Exp Biol Med 230: 777-784
< JK, Xia J, Grondin JM, Engle SK, Jakubowski JA https://doi.org/10.1177/153537020523001012>
13. 2011: Zucker diabetic fatty rat: A new model of impaired cutaneous wound repair with type II diabetes mellitus and obesity. Wound Rep Reg 19: 515-525
< R, Kohlerova R, Tkacova V, Jiroutova A, Tahmazoglu B, Velebny V, Rezacova M, Sobotka L, Kanta J https://doi.org/10.1111/j.1524-475X.2011.00703.x>
14. 2009: Matrix metalloproteinase-3 accelerates wound healing following dental pulp injury. Am J Pathol 175: 1905-1914
< L, Amano K, Iohara K, Ito M, Imabayashi K, Into T, Matsushita K, Nakamura H, Nakashima M https://doi.org/10.2353/ajpath.2009.080705>